Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>=18 years and \< 65 years~* Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas.~* Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain)~* Diagnosis confirmed by non contrast CT KUB within the ED visit.~Exclusion Criteria:~* Traumatic flank pain~* Pregnancy~* Known renal failure or impairment~* Known allergy to morphine, diclofenac or paracetamol~* Bronchial asthma~* Previously enrolled in the study.~* Use of any analgesia in last 6 hour.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Diclofenac and Placebos (Type: EXPERIMENTAL): Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.
- Morphine and Placebos (Type: ACTIVE_COMPARATOR): Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.
- Paracetamol and Placebos (Type: ACTIVE_COMPARATOR): participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.

Based on this trial design, predict the completion outcome and termination type (if applicable).